File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Causal relationships between gut metabolites and Alzheimer's disease: a bidirectional Mendelian randomization study

TitleCausal relationships between gut metabolites and Alzheimer's disease: a bidirectional Mendelian randomization study
Authors
KeywordsAlzheimer's disease
Trimethylamine N-oxide
Mendelian randomization
Causality
Genetic association
Issue Date2021
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/neuaging
Citation
Neurobiology of Aging, 2021, v. 100, p. 119.e15-119.e18 How to Cite?
AbstractObservational studies have shown that gut microbiota–dependent metabolites are associated with the risk of Alzheimer's disease (AD). However, whether such association reflects a causality remains unclear. We conducted a bidirectional Mendelian randomization analysis to examine the causal relationships between gut microbiota–dependent metabolites trimethylamine N-oxide (TMAO) or its predecessors and AD. We observed that genetically predicted TMAO (odds ratio: 0.99, 95% confidence interval: 0.89 to 1.09 per 10 units, p = 0.775) or its predecessors including betaine (1.06, 1.00 to 1.12 per 10 units, p = 0.056), carnitine (1.05, 0.98 to 1.12 per 10 units, p = 0.178), and choline (1.01, 0.92 to 1.10 per 10 units, p = 0.905) were not associated with the risk of AD. Our Mendelian randomization estimates from AD to metabolites showed that genetically predicted higher risk of AD was also not causally associated with TMAO, betaine, carnitine, and choline levels. Our findings support that gut microbiota–dependent metabolites TMAO or its predecessors do not play causal roles in the development of AD.
Persistent Identifierhttp://hdl.handle.net/10722/305895
ISSN
2023 Impact Factor: 3.7
2023 SCImago Journal Rankings: 1.488
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorZhuang, Z-
dc.contributor.authorGao, M-
dc.contributor.authorYang, R-
dc.contributor.authorLiu, Z-
dc.contributor.authorCao, W-
dc.contributor.authorHuang, T-
dc.date.accessioned2021-10-20T10:15:51Z-
dc.date.available2021-10-20T10:15:51Z-
dc.date.issued2021-
dc.identifier.citationNeurobiology of Aging, 2021, v. 100, p. 119.e15-119.e18-
dc.identifier.issn0197-4580-
dc.identifier.urihttp://hdl.handle.net/10722/305895-
dc.description.abstractObservational studies have shown that gut microbiota–dependent metabolites are associated with the risk of Alzheimer's disease (AD). However, whether such association reflects a causality remains unclear. We conducted a bidirectional Mendelian randomization analysis to examine the causal relationships between gut microbiota–dependent metabolites trimethylamine N-oxide (TMAO) or its predecessors and AD. We observed that genetically predicted TMAO (odds ratio: 0.99, 95% confidence interval: 0.89 to 1.09 per 10 units, p = 0.775) or its predecessors including betaine (1.06, 1.00 to 1.12 per 10 units, p = 0.056), carnitine (1.05, 0.98 to 1.12 per 10 units, p = 0.178), and choline (1.01, 0.92 to 1.10 per 10 units, p = 0.905) were not associated with the risk of AD. Our Mendelian randomization estimates from AD to metabolites showed that genetically predicted higher risk of AD was also not causally associated with TMAO, betaine, carnitine, and choline levels. Our findings support that gut microbiota–dependent metabolites TMAO or its predecessors do not play causal roles in the development of AD.-
dc.languageeng-
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/neuaging-
dc.relation.ispartofNeurobiology of Aging-
dc.subjectAlzheimer's disease-
dc.subjectTrimethylamine N-oxide-
dc.subjectMendelian randomization-
dc.subjectCausality-
dc.subjectGenetic association-
dc.titleCausal relationships between gut metabolites and Alzheimer's disease: a bidirectional Mendelian randomization study-
dc.typeArticle-
dc.identifier.emailLiu, Z: zhhliu@hku.hk-
dc.identifier.authorityLiu, Z=rp02429-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.neurobiolaging.2020.10.022-
dc.identifier.pmid33280888-
dc.identifier.scopuseid_2-s2.0-85097254038-
dc.identifier.hkuros327209-
dc.identifier.volume100-
dc.identifier.spage119.e15-
dc.identifier.epage119.e18-
dc.identifier.isiWOS:000621893900017-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats